MetSyn
Product description
Probiotic complex targeting the metabolic syndrome composed
by L. plantarum - PBS067, L. acidophilus PBS066 and L. reuteri PBS072. Their selection comes
from a priori in-vitro screening on
their ability in improving both lipid and carbohydrates metabolism, as well as
in modulating the inflammation process.
SynBalance® MetSyn has been then clinically tested in a randomized double blind placebo controlled clinical trial, underlining a positive effect on body circumference and visceral adiposity, besides restoration of healthy lipid metabolic profile, modulation of chronic inflammation and improvement of life quality.
Read more
SynBalance® MetSyn has been then clinically tested in a randomized double blind placebo controlled clinical trial, underlining a positive effect on body circumference and visceral adiposity, besides restoration of healthy lipid metabolic profile, modulation of chronic inflammation and improvement of life quality.
Specifications
Categories | Probiotics |
---|---|
Sales markets | Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Central/South America |
Supplied from | Italy |
Product Applications | Dietary Supplements; Food Supplements; Pharmaceutical |
Product Certifications | Sustainable Seafood |
More products from SYNBALANCE SRL
Products from other suppliers
❮
❯
-
COLLAGEN POWDER BLEND
-
Collasel Hydrolyzed Collagen Peptide
-
Cartidyss, much more than collagen peptides
-
Crispact® Stick packs
-
Huanarpo Macho
-
PRONULIFE®LvUCare-Uric Acid Management and Liver Care Probiotics
-
Care300® - Glucose management
-
Starch 1500® Partially Pregelatinized Maize Starch
-
BCM-95® (biocurcumin®)
-
ALPAVIT Lactose Pharma
MetSyn